# Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression

> **NCT03441282** · — · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 26 (actual)

## Conditions studied

- Respiratory Depression

## Interventions

- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03441282
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-30
- **Primary completion:** 2025-05-21
- **Final completion:** 2025-05-21
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** Investigator decision
- **Last updated:** 2025-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03441282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03441282, "Precision Medicine in Anesthesia: Genetic Component in Opioid-induced Respiratory Depression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03441282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*